Toggle Summary November 2, 2015
Minerva Neurosciences Announces Appointment of Dr. David Kupfer to Its Board of Directors
View HTML
Toggle Summary November 5, 2015
Minerva Neurosciences Reports Third Quarter 2015 Financial Results and Business Updates
View HTML
Toggle Summary November 13, 2015
Minerva Neurosciences to Present at Jefferies 2015 London Healthcare Conference on November 18, 2015
View HTML
Toggle Summary December 9, 2015
Minerva Provides Year-End Update on Clinical Trials With Three Central Nervous System Product Candidates
Patient Enrollment Progress During 2015 Confirms Timeline Expectations for Topline Data Availability From Four Trials in First Half of 2016
View HTML
Toggle Summary December 18, 2015
Minerva Achieves Enrollment Target in Phase IIb Trial With MIN-101
WALTHAM, Mass., Dec. 18, 2015 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it has met its enrollment target of 234 patients in
View HTML
Toggle Summary December 29, 2015
Minerva Neurosciences Announces Update on MIN-101 Clinical Development Program
Enrollment Completed in European Phase IIb Trial and Investigational New Drug (IND) Application Accepted by U.S. FDA
View HTML
Toggle Summary January 11, 2016
Minerva Neurosciences Announces Favorable Top Line Results From MIN-202 Phase 2A Clinical Trial in Insomnia Disorder
Consistent Improvements Observed With Selective Orexin-2 Receptor Antagonist in Multiple Parameters of Sleep Induction and Maintenance
View HTML
Toggle Summary February 1, 2016
Minerva Neurosciences Announces Top Line Data From MIN-202 Phase I Clinical Study in Japanese Patients
View HTML
Toggle Summary February 22, 2016
Minerva Neurosciences Announces Completion of Patient Enrollment in Phase IIa Trial of MIN-117 in Major Depressive Disorder
View HTML
Toggle Summary March 7, 2016
Minerva Neurosciences to Report Fiscal 2015 Fourth Quarter and Year End Financial Results and Business Updates on March 14, 2016
Management to Host Conference Call
View HTML
